10.24335/L28001
RoyaltyStat
Collaborative development, with exclusive patent, know-how and technology license to make, have made, use, sell, offer, import, export, transfer and sublicense small molecule or large molecule pharmaceuticals that interact with the Rare Osteogenic Kindred gene, protein products or pathway, for human therapeutic, prophylactic, palliative and diagnostic uses.
RoyaltyStat
2003